FDA Recalls Affymax Omontys

By: Benzinga
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary recall of all lots of Omontys injection. Omontys, manufactured by Affymax (NASDAQ: AFFY ) and Takeda Pharmaceuticals, Ltd., is used to treat anemia in adult dialysis patients. It is a man-made protein that aids
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.